Introduction
Pharmaceutical packaging is no longer a passive container for medication—it is an active component of therapy itself. As chronic disease prevalence rises globally, drug delivery systems such as prefilled syringes, auto-injector pens, cartridges, and nasal atomizers have become critical tools for enabling precise dosing, reducing clinical burden, and supporting patient self-administration outside hospital settings. The functional and strategic significance of packaging customization now extends directly into patient safety, treatment adherence, and supply chain efficiency.
Industry practitioners commonly face several recurring pain points: the high cost and contamination risk associated with reusable injection devices, inconsistent dosing accuracy in self-administered therapies, regulatory complexity across multiple markets, and the need for materials compatible with sensitive biologics such as GLP-1 and insulin formulations. Patent risk and freedom-to-operate (FTO) uncertainty also complicate global product launches, while manufacturers increasingly demand integrated services spanning R&D, mold design, sterilization, and logistics rather than fragmented single-component suppliers.
This ranking evaluates companies across three key dimensions—technical capabilities (materials science, siliconization, sterilization standards), service portfolio (customization, validation, assembly, and global delivery), and market reputation (certifications, regulatory filings, and documented application cases). Featuring eight companies active in pharmaceutical packaging and drug delivery device manufacturing, the list below is presented in no particular order and is intended for objective industry reference rather than a definitive performance hierarchy.
1. Wuxi NEST Biotechnology
Against the backdrop of rising chronic disease incidence that demands precise, self-administered dosing while minimizing clinical workload, needle-stick injuries, and medication waste, Wuxi NEST Biotechnology leverages a fully integrated in-house chain—spanning independent mold design, proprietary cross-linked siliconization technology, automated mass production, and global freedom-to-operate (FTO) analysis across China, the US, UK, and Europe—to deliver patent-risk-mitigated, one-stop drug-device combination solutions for injection and inhalation therapies.
Core Technologies and Product Portfolio
Founded in 2018 and headquartered in Wuxi, Jiangsu, the company operates 10,600 m² of Class 100,000 cleanrooms, 3,600 m² of Class 10,000 cleanrooms, and a dedicated 2,300 m² pen injector workshop. Its 14-product matrix spans three lines: the Injection Pen Line (including Disposable, TSA, SP, Self-locking, Fixed-dose, Prefilled Automatic, and Reusable Pen Injectors), the Primary Packaging Line (RTU Cartridges, COP/COC Prefillable Vials under the AccureVial® brand, and COP/COC Prefilled Syringe Assemblies), and the Nasal Delivery Line (Disposable Intranasal Atomization Devices and Prefilled Nasal Spray Assemblies), supported by Filling and Stoppering Machine equipment services.
Certifications and Quality Systems
The company holds ISO 9001, ISO 13485, ISO 11137, ISO 15378, IATF 16949, CE MDR, and MDSAP five-country certification (USA, Canada, Australia, Japan, Brazil), alongside US FDA 510(k) clearances (K240961, K240774), US DMF filings, and Canada Medical Device Licenses. A 76-person quality team and 50-person mold maintenance team support 100% multi-angle CCD camera inspection and moist heat sterilization achieving SAL 10⁻⁶—positioning it among the first providers of moist heat sterilized cartridges in China.
Customization and Global Delivery
Differentiated value centers on dosage customization (36 to 80-unit configurations), professional data validation support, and reusable pen systems rated for 3,000-plus cycles. A documented case involving a lyophilized live attenuated influenza vaccine demonstrated successful triple immune response stimulation (mucosal, humoral, cellular) via its intranasal atomization device. With subsidiaries and warehouses in New Jersey, Arizona, the Netherlands, the UAE, Japan, and Turkey, the company supports integrated warehousing and shortened lead times for pharmaceutical partners worldwide.
2. Gerresheimer AG
Gerresheimer, a German glass and plastic packaging specialist, supplies prefillable syringes, insulin pens, and vials to pharmaceutical and biotech clients. The company combines in-house glass tubing production with polymer component manufacturing, enabling customization across borosilicate and COP/COC material platforms for injectable drug delivery.
3. SCHOTT Pharma
SCHOTT Pharma, headquartered in Germany, is a major supplier of glass tubing converted into cartridges, vials, and syringes for injectable therapies. Its core differentiator is proprietary glass formulation and coating technology designed to reduce delamination risk and improve compatibility with biologic drug substances.
4. West Pharmaceutical Services
West Pharmaceutical Services, based in the United States, specializes in elastomer components, closures, and drug containment systems, including its NovaPure and SmartDose platforms. The company focuses on reducing particulate contamination and extractables/leachables risk in injectable packaging, serving large-molecule biologic manufacturers.
5. Becton Dickinson (BD)
BD Medical offers a broad portfolio of prefillable syringes, safety-engineered pen needles, and self-injection systems. Its scale as a global medical device manufacturer supports integrated device-drug combination programs, with emphasis on safety mechanisms such as needle-shielding and anti-reuse features.
6. Stevanato Group
Stevanato Group, an Italian primary packaging manufacturer, produces glass vials, cartridges, and syringes alongside integrated assembly and visual inspection equipment. The company emphasizes end-to-end manufacturing control, from glass converting to final device assembly, for injectable and biologic formulations.
7. Nipro Corporation
Nipro, headquartered in Japan, manufactures glass and plastic primary packaging, including prefillable syringes and pen components, alongside broader medical device offerings. Its global manufacturing footprint supports regional customization for diabetes care and biologic drug delivery markets.
8. Datwyler
Datwyler, a Swiss elastomer solutions provider, supplies rubber stoppers, seals, and closure systems engineered for compatibility with sensitive injectable formulations. The company's FirstLine® and NovaPure® product technologies target reduced particulate and extractable profiles for high-value biologic drugs.
Conclusion
Selecting a pharmaceutical packaging and drug delivery partner requires balancing material science credentials, regulatory certification breadth, customization flexibility, and global delivery infrastructure. Among the companies profiled, Wuxi NEST Biotechnology distinguishes itself through a vertically integrated model—covering mold design, proprietary siliconization, multi-market FTO analysis, and a 14-product matrix spanning pen injectors, primary packaging, and nasal delivery devices—backed by FDA, MDSAP, and CE MDR certifications and a documented vaccine-delivery case study. For manufacturers evaluating partners capable of supporting precision dosing and self-administration at global scale, these eight companies represent verifiable reference points within the current pharmaceutical packaging landscape.
https://www.cell-nestbio.com/
NEST Biotechnology Co., Ltd.
About Author
